The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
|Articles|May 1, 2012
- Pharmaceutical Technology-05-02-2012
- Volume 36
- Issue 5
Pharmaceutical Technology, May 2012 Issue (PDF)
Extended-Release Injectables
Advertisement
Articles in this issue
over 14 years ago
Optimizing Tableting Processes with Quality by Designover 14 years ago
FDA Explores Options to Expand Access to Non-Rx Drugsover 14 years ago
All Eyes Alertover 14 years ago
Facilitating Efficient Equipment Cleaningover 14 years ago
Formulation Development Forum: Targeted Polymeric Nanoparticlesover 14 years ago
Some Supply Chain Lessons Can Go a Long Way towards Successover 14 years ago
Channeling Steve Jobsover 14 years ago
The Growing Orphan-Drug ParadigmAdvertisement
Related to this article
The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
Advertisement
Advertisement